Competitive advantages

••• Rheoderm® vs Topical HA

  • Because of its large molecular weight, HA in creams, lotions and serums is unable to cross the stratum corneum. It sits on the surface as a humectant and film. Rheoderm® reaches the dermis by the systemic route, acting at a depth topical application can’t reliably achieve.

  • Topical HA delivers passive surface hydration, whereas Rheoderm® stimulates the skin’s own production of HA and collagen, so the effect is biological and structural, not just a moisturizing action on the outermost layer.

  • Topical HA only works where you spread it and only while the barrier is intact, whereas Rheoderm® acts body-wide (face, neck, hands etc.) and doesn’t depend on penetration or skin condition.

••• Rheoderm® vs injectable HA

  • Injected HA acts only where the needle goes, whereas Rheoderm® acts body-wide (face, neck, décolleté, hands etc.) in a single daily dose.

  • Injection places an exogenous gel that the body will resorb, whereas Rheoderm® instead stimulates the skin’s own HA production, so the benefit is physiological and self-organized within the matrix, not a foreign deposit.

  • HA dermal fillers target volume alone, whereas Rheoderm® also improves skin radiance, hydration, firmness and elasticity, and prevents collagen, elastin, and native HA breakdown.

  • Rheoderm® is non-invasive: no needle, no office visits and no risk of adverse events associated with injections such as nodules, granulomas or Tyndall effect.